CERSCI THERAPEUTICS
CerSci Therapeutics, a non-opioid drug development firm based in Dallas, Texas, has received approval of their Investigational New Drug (IND) application for CT-044 from the United States Food and Drug Administration (FDA) indicating that its Phase I safety and tolerability clinical trial may proceed (commence phase I dosing June 2019). CT-044, a non-metal based, orally bioavailable, small molecule Radical Species Decomposition Accelerant (RSDAx) of peroxynitrite and hydrogen peroxide, is proposed for the treatment of acute and chronic pain, including acute post-surgical pain and painful diabetic neuropathy.
CERSCI THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Neuroscience Pharmaceutical Therapeutics
Founded:
2015-02-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.cersci.com
Total Employee:
1+
Status:
Closed
Total Funding:
13.88 M USD
Technology used in webpage:
Amazon Google Apps For Business GoDaddy DNS Amazon Virginia Region WPForms
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - CerSci Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - CerSci Therapeutics
Official Site Inspections
http://www.cersci.com
- Host name: ec2-52-55-23-95.compute-1.amazonaws.com
- IP address: 52.55.23.95
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
